missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LGSN (aa 223-313) Control Fragment Recombinant Protein
Click to view available options
Quantité:
100 μl
Conditionnement:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (86%), Rat (86%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56601 (PA5-56601. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
May act as a component of the cytoskeleton or as a chaperone for the reorganization of intermediate filament proteins during terminal differentiation in the lens. Does not seem to have enzymatic activity.
Spécification
Spécification
| Numéro d’adhésion | Q5TDP6 |
| Concentration | ≥5.0 mg/mL |
| À utiliser avec (application) | Blocking Assay, Control |
| Formule | 1 M urea, PBS with no preservative; pH 7.4 |
| Identification génétique (Entrez) | 51557 |
| Nom | Human LGSN (aa 223-313) Control Fragment |
| Quantité | 100 μl |
| État réglementaire | RUO |
| Alias de gène | GLULD1; glutamate-ammonia ligase (glutamine synthase) domain containing 1; glutamate-ammonia ligase domain-containing protein 1; Lengsin; lengsin, lens protein with glutamine synthetase domain; Lens glutamine synthase-like; LGS; LGSN |
| Nom usuel | LGSN |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu